RE: RNS1 Jul 2022 18:42
This sounds pretty upbeat, from the RNS:
"4D pharma is working with the administrators to enable an exit from administration as soon as possible and, in the event that the company does exit administration, currently plans to recommence recruitment so long as additional capital funding is secured. Further announcements will be made in due course".